Saul Fink – Biography

Last update: April 1, 2026

Executive profile

Saul was Senior Vice President, Pharmaceutical & Nonclinical Development at Normunity, and Vice President, Pharmaceutical Development and Interim Lead, Non-Clinical Development at Goldfinch Bio.

Saul Fink is currently

Chief Technology Officer at Q32 Bio - View - Q32 Bio org chart



Create your alert
to follow the career of Saul Fink.

Education

Saul Fink has a PhD in Chemistry from University of Houston.

They have also studied at University of Houston :

Find more alumni from University of Houston

More about Saul Fink

The colleagues of Saul Fink

Company Colleagues
Industry Colleagues
  • In the Biotechnology industry, Saul Fink has 35,756 colleagues in 2,407 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.

Report an error
Update the org chart details of Saul Fink.

Get in Touch

Here are a few tips for establishing great contacts.

Through the switchboard, call Q32 Bio at +1 917... and ask for Saul Fink.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.